TNNT2 variants in DCM cohorts


The table below lists the 25 rare (MAF<0.0001 in ExAC) protein-altering TNNT2 variants identified in a cohort of 756 DCM patients. When this rare variant frequency of 0.03307 is compared with a background population rate of 0.00242, there is a statistically significant case excess of 0.03065 (p<0.0001), which suggests that approximately 23 of these variants may be pathogenic.


Variant Type:      All protein-altering variants     -     Truncating variants     -     Non-Truncating variants
Source:      Combined (OMGL + LMM)     -     OMGL     -     LMM



No. Variant (CDS) Variant (Protein) Variant Type Cases (756)LMM class ExAC frequency
1. c.629_631delAGA inframe 11Pathogenic0.000000
2. c.421C>T p.R141Wmissense 5Pathogenic0.000000
3. c.325C>T p.H109Ymissense 1VUS favour pathogenic0.000000
4. c.400C>G p.R134Gmissense 1Likely Pathogenic0.000000
5. c.178A>G p.M60Vmissense 1VUS0.000049
6. c.415C>T p.R139Cmissense 1VUS0.000000
7. c.392G>A p.R131Qmissense 1Likely Pathogenic0.000000
8. c.530C>A p.A177Dmissense 1VUS0.000000
9. c.416G>A p.R139Hmissense 1Likely Pathogenic0.000000
10. c.734C>T p.A245Vmissense 1VUS0.000008
11. c.391C>T p.R131Wmissense 1VUS favour pathogenic0.000008

References

1. Roddy Walsh, Kate L. Thomson, James S. Ware, Birgit H. Funke, Jessica Woodley, Karen J. McGuire, Francesco Mazzarotto, Edward Blair, Anneke Seller, Jenny C. Taylor, Eric V. Minikel, Exome Aggregation Consortium, Daniel G. MacArthur, Martin Farrall, Stuart A. Cook and Hugh Watkins. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016 doi:10.1038/gim.2016.90.

2. Pugh TJ, Kelly MA, Gowrisankar S, Hynes E, Seidman MA, Baxter SM, Bowser M, Harrison B, Aaron D, Mahanta LM, Lakdawala NK, McDermott G, White ET, Rehm HL, Lebo M, Funke BH. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med. 2014 Aug;16(8):601-8.